Already 490 people have seen this company's branding but they do not have any followers.In average the company has been rated 4.8 points but has not been commented.

's activity report 2022

Naerusuine OÜ was established on 21.02.2020 and the main activity of the company is the retail sale of medicines, medicinal-like substances, dietary supplements and medical equipment.

Operations started on 01.04.2020, when four pharmacies and one branch pharmacy were acquired.

In 2022, the company's turnover was 6,917 thousand euros (in 2021 the turnover was 6,359 thousand euros). As of the end of the 2022 financial year, the company had 5 pharmacies, three of which are located in Tallinn, one in Viimsi and one in Rapla. (In 2021, the company had 5 pharmacies in the same locations). In 2023, there are plans to open one new pharmacy.

The wage cost for 2022, including social taxes, was 846 thousand euros and the number of full-time equivalent employees was 26. (In 2021, 698 thousand euros and the average number of full-time equivalent employees was 23).

The company actively participates in EPAL's work and as a result, regular vaccination takes place in the company's pharmacies, which has a positive effect on the number of customers and the increase in turnover.

In 2022, Covid did not affect the company's operations, at the beginning of the year, major sales related to Covid tests ended, for 2023

The impact of Covid is not visible at the time of preparing the annual report. Due to the outbreak of the war in Ukraine in February 2022, sales in pharmacies increased in February and March, as people stocked up on medicines, similar effects are not foreseen for 2023. The general economic situation has also caused supply problems for some medicines and therefore sales in 2022 may be affected. In 2023, high interest rates and the general high inflation situation are expected to affect the demand for non-drugs, which puts consumption under pressure (including

pharmacy goods).

The company continues to operate as a business entity. In order to provide pharmacy services at a high level to customers and to acquire expertise in operating a pharmacy, the company's pharmacies operate under the BENU brand and use the BENU pharmacy franchise concept.

The company's key financial indicators and ratios: 2021 2022

Gross profit (thousand EUR) 1,023 1,126

Gross profit margin 16% 16%

Net profitability 0.01% -0.08%

Formulas used in calculating ratios, financial indicators: a. Gross profit = sales revenue - goods, raw materials, materials and services b. Gross profit margin (%) = gross profit / sales revenue * 100 c. Net profitability (%) = net profit / sales revenue * 100